LncRNAs and Rheumatoid Arthritis: From Identifying Mechanisms to Clinical Investigation DOI Creative Commons
Wentao Huang, Xue Li, Chen Huang

и другие.

Frontiers in Immunology, Год журнала: 2022, Номер 12

Опубликована: Янв. 11, 2022

Rheumatoid arthritis (RA) is a systemic chronic autoinflammatory disease, and the synovial hyperplasia, pannus formation, articular cartilage damage bone matrix destruction caused by immune system abnormalities are main features of RA. The use Disease Modifying Anti-Rheumatic Drugs (DMARDs) has achieved great advances in therapy Yet there still patients facing problem poor response to drug or intolerance. Current methods can only moderate RA progress, but cannot stop reverse it caused. Recent studies have reported that variety long non-coding RNAs (LncRNAs) been implicated mediating many aspects Understanding mechanism LncRNAs therefore critical for development new strategies prevention strategies. In this review, we systematically elucidate biological roles mechanisms action their Additionally, also highlight potential value clinical diagnosis

Язык: Английский

Therapeutic potential in rheumatic diseases of extracellular vesicles derived from mesenchymal stromal cells DOI
Giuliana Minani Bertolino,

Marie Maumus,

Christian Jørgensen

и другие.

Nature Reviews Rheumatology, Год журнала: 2023, Номер 19(11), С. 682 - 694

Опубликована: Сен. 4, 2023

Язык: Английский

Процитировано

30

Extracellular vesicles as a novel mediator of interkingdom communication DOI
Jumin Huang,

Xuan‐Run Wang,

Ziming Wang

и другие.

Cytokine & Growth Factor Reviews, Год журнала: 2023, Номер 73, С. 173 - 184

Опубликована: Авг. 21, 2023

Язык: Английский

Процитировано

29

Mesenchymal stromal cells-derived extracellular vesicles in cartilage regeneration: potential and limitations DOI Creative Commons
María Piñeiro-Ramil,

Iván Gómez-Seoane,

Ana Isabel Rodríguez-Cendal

и другие.

Stem Cell Research & Therapy, Год журнала: 2025, Номер 16(1)

Опубликована: Янв. 23, 2025

Articular cartilage injuries can lead to pain, stiffness, and reduced mobility, may eventually progress osteoarthritis (OA). Despite substantial research efforts, effective therapies capable of regenerating are still lacking. Mesenchymal stromal cells (MSCs) known for their differentiation immunomodulatory capabilities, yet challenges such as limited survival post-injection inconsistent therapeutic outcomes hinder clinical application. Recent evidence suggests that the beneficial effects MSCs largely mediated by secreted small extracellular vesicles (sEVs), which have been shown promote tissue repair reduce inflammation. MSC-derived sEVs promise in mitigating degradation chondrocyte apoptosis, positioning them a promising alternative MSC-based OA treatment. This review explores potential limitations regeneration. systematic was conducted following PRISMA guidelines, with comprehensive search Web Science Scopus databases studies published between 2019 2024. A total 223 records were identified, 132 articles assessed eligibility based on general selection criteria. After full-text screening, 60 initially selected, comprising 58 vitro 40 vivo studies. Following further exclusion specific criteria, 33 28 from 47 scientific papers included final qualitative synthesis. Most indicate enhance proliferation, improve matrix composition, matrix-degrading enzymes inflammation, thereby delaying progression. growing body supports use tool preventing progression, most reporting structure function. However, remain optimizing standardizing isolation, dosage, delivery methods Further is necessary elucidate mechanisms underlying sEVs-mediated regeneration facilitate translation into therapies.

Язык: Английский

Процитировано

1

Natural and Bioengineered Extracellular Vesicles in Diagnosis, Monitoring and Treatment of Cancer DOI
Xin Luo, Kathleen M. McAndrews, Raghu Kalluri

и другие.

ACS Nano, Год журнала: 2025, Номер unknown

Опубликована: Янв. 27, 2025

Extracellular vesicles (EVs) are cell derived nanovesicles which implicated in both physiological and pathological intercellular communication, including the initiation, progression, metastasis of cancer. The exchange biomolecules between stromal cells cancer via EVs can provide a window to monitor development real time for better diagnostic interventional strategies. In addition, process secretion internalization by tumor microenvironment (TME) be exploited delivering therapeutics. have potential targeted, biocompatible, efficient delivery platform treatment other diseases. Natural as well engineered nanomedicine immense disease intervention. Here, we an overview current knowledge EVs' function therapeutic applications setting, EV engineering

Язык: Английский

Процитировано

1

Exosomes in the Pathogenesis, Progression, and Treatment of Osteoarthritis DOI Creative Commons
Yishu Fan, Zhong Li, Yuchen He

и другие.

Bioengineering, Год журнала: 2022, Номер 9(3), С. 99 - 99

Опубликована: Фев. 27, 2022

Osteoarthritis (OA) is a prevalent and debilitating age-related joint disease characterized by articular cartilage degeneration, synovial membrane inflammation, osteophyte formation, as well subchondral bone sclerosis. OA drugs at present are mainly palliative do not halt or reverse progression. Currently, no disease-modifying (DMOADs) available total arthroplasty remains last resort. Therefore, there an urgent need for the development of efficacious treatments management. Among all novel pharmaco-therapeutical options, exosome-based therapeutic strategies highly promising. Exosome cargoes, which include proteins, lipids, cytokines, various RNA subtypes, potentially capable regulating intercellular communications gene expression in target cells tissues involved development. With extensive research recent years, exosomes studies longer limited to classic, mesenchymal stem cell (MSC)-derived vesicles. New origins, structures, functions constantly being discovered investigated. This review systematically summarizes non-classic biosynthesis, extraction exosomes, describes modification delivery techniques, explores their role pathogenesis progression, discusses potential hurdles overcome treatment.

Язык: Английский

Процитировано

34

Chondrogenic primed extracellular vesicles activate miR-455/SOX11/FOXO axis for cartilage regeneration and osteoarthritis treatment DOI Creative Commons
Ye Sun, Jie Zhao, Qiang Wu

и другие.

npj Regenerative Medicine, Год журнала: 2022, Номер 7(1)

Опубликована: Сен. 16, 2022

Osteoarthritis (OA) is the leading cause of disability worldwide. Considerable progress has been made using stem-cell-derived therapy. Increasing evidence demonstrated that therapeutic effects BMSCs in chondrogenesis could be attributed to secreted small extracellular vesicles (sEVs). Herein, we investigated feasibility applying engineered EVs with chondrogenic priming as a biomimetic tool chondrogenesis. We derived from TGFβ3-preconditioned presented enriched specific miRNAs transferred native promote In addition, found rich miR-455 promoted OA alleviation and cartilage regeneration by activating SOX11/FOXO signaling pathway. Moreover, designed T3-EV hydrogel showed great potential defect treatment. Our findings provide new means apply biosafe primed-BMSCs for repair treatment, expanding understanding development modulated EV-miRNAs vivo.

Язык: Английский

Процитировано

31

Quantitative and functional characterisation of extracellular vesicles after passive loading with hydrophobic or cholesterol-tagged small molecules DOI Creative Commons

Gwenola Tréton,

Cláudia Sayer, Melanie Schürz

и другие.

Journal of Controlled Release, Год журнала: 2023, Номер 361, С. 694 - 716

Опубликована: Авг. 19, 2023

Extracellular vesicles (EVs) are nanosized intercellular messengers that bear enormous application potential as biological drug delivery vehicles. Much progress has been made for loading or decorating EVs with proteins, peptides RNAs using genetically engineered donor cells, but post-isolation synthetic drugs and from natural sources remains challenging. In particular, quantitative unambiguous data assessing whether how small molecules associate versus other components in the samples still lacking. Here we describe systematic characterisation of passive EV based on hydrophobic interactions - either through direct adsorption compounds, by membrane anchoring hydrophilic ligands via cholesterol tags. As revealed single vesicle imaging, both ligand types bind to CD63 positive (exosomes), however also non-specifically vesicles, particles, serum proteins. The compounds Curcumin Terbinafine aggregate no apparent saturation up 106-107 per quantified liquid chromatography high resolution mass spectrometry (LC-HRMS). For density resulted formation a population large, electron-dense detected cryo-transmission electron microscopy (TEM), reduced cell uptake toxic gain function Curcumin-EVs. contrast, tagging mdm2-targeted cyclic peptide saturated at densities ca 104-105 vesicle, lipidomics showing addition to, rather than replacement endogenous cholesterol. Cholesterol anchored did not change EVs' size morphology, such retained their activity without inducing toxicity. However, cholesterol-anchored were rapidly shed presence serum. Based these data, conclude (1) methods allow prone unspecific compound binding redistribution if present sample, (2) needs substantial optimization formulation stability vivo applications, whereas (3) careful titration is warranted when relying mitigate changes physicochemical properties, loss

Язык: Английский

Процитировано

19

Protein Biocargo and Anti-Inflammatory Effect of Tomato Fruit-Derived Nanovesicles Separated by Density Gradient Ultracentrifugation and Loaded with Curcumin DOI Creative Commons
Ramila Mammadova, Serena Maggio, Immacolata Fiume

и другие.

Pharmaceutics, Год журнала: 2023, Номер 15(2), С. 333 - 333

Опубликована: Янв. 19, 2023

Plant-derived nanovesicles (PDNVs) have become attractive alternatives to mammalian cell-derived extracellular vesicles (EVs) both as therapeutic approaches and drug-delivery vehicles. In this study, we isolated tomato fruit-derived NVs separated them by the iodixanol density gradient ultracentrifugation (DGUC) into twelve fractions. Three visible bands were observed at densities 1.064 ± 0.007 g/mL, 1.103 0.006 g/mL 1.122 0.012 g/mL. Crude PDNVs DGUC fractions characterized particle size-distribution, concentration, lipid protein contents well composition using mass spectrometry-based proteomics. Cytotoxicity anti-inflammatory activity of associated these assessed in lipopolysaccharide (LPS)-stimulated human monocytic THP-1 cell culture. The middle low-density showed a significant reduction LPS-induced inflammatory IL-1β cytokine mRNA production. Functional analysis proteins identified reveals presence 14-3-3 proteins, endoplasmic reticulum luminal binding GTP gene ontology (GO) term GO:0050794 regulation several cellular processes including inflammation. most abundant middle-density fraction was loaded with curcumin direct loading, sonication extrusion methods compared. highest entrapment efficiency drug loading capacity obtained loading. Curcumin increased basal PDNVs.

Язык: Английский

Процитировано

17

Exploring potential of exosomes drug delivery system in the treatment of cancer: Advances and prospective DOI Creative Commons

Deepika Yadav,

Rishabha Malviya

Medicine in Drug Discovery, Год журнала: 2023, Номер 20, С. 100163 - 100163

Опубликована: Окт. 12, 2023

Exosomes are vital for cellular communication and the transfer of materials between cells. Recently, it has been shown that nanoparticles may be used as diagnostic indicators a potential medicine delivery strategy due to their nanoscale size capacity carry biological components target have an appealing practical approach drug administration in cancer treatment biocompatibility, high stability, favoured tumour homing, adjustable targeting efficacy. While exosomes properties make them useful transporting bioactive compounds, gap our present understanding exosome biology most optimal condition use remains. The rationale using strategy, production purification, bioengineering targeting, uptake distribution, efficacy, immune response, other factors will all discussed this study. Modern methods required observing, categorising, sorting diversity. Improvements nanotechnology knowledge undoubtedly speed up field's medical uses.

Язык: Английский

Процитировано

16

Therapeutics of the future: Navigating the pitfalls of extracellular vesicles research from an osteoarthritis perspective DOI Creative Commons
Antoine Karoichan,

Sarah Boucenna,

Maryam Tabrizian

и другие.

Journal of Extracellular Vesicles, Год журнала: 2024, Номер 13(7)

Опубликована: Июнь 28, 2024

Abstract Extracellular vesicles have gained wide momentum as potential therapeutics for osteoarthritis, a highly prevalent chronic disease that still lacks an approved treatment. The membrane‐bound are secreted by all cells carrying different cargos can serve both biomarkers and modifiers. Nonetheless, despite significant peak in research regarding EVs OA therapeutics, clinical implementation seems distant. In addition to scalability standardization challenges, researchers often omit focus on consider the proper tropism of vesicles, practicality relevance their source, low native therapeutic efficacy, whether they address whole. These considerations necessary better understand light been comprehensively discussed ultimately summarized this review into conceptualized framework termed nanodiamond concept. Future perspectives also discussed, alternatives presented some challenges concerns.

Язык: Английский

Процитировано

6